Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Whole body low dose CT scan: Whole body low dose CT scan will be done in all cases and compared with bone scan for detecting bone metastasis
Control Intervention1: Whole body low dose C
Sponsors
All India Institute of Medical Sciences New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Patients with carcinoma breast with primary tumor size of 5cm or more, biopsy or FNAC proven axillary lymph node metastasis, AJCC TNM Stage III (anatomic staging), AJCC TNM Stage IV (anatomic staging), patients of any stage having symptoms or biochemical abnormality which could be attributable to metastasis, treated cases of carcinoma breast suspected of developing metastasis
Exclusion criteria
Exclusion criteria: Pregnant women, non consenting patients, Patient with history of allergy to iodinated contrast and those with deranged Kidney function test will undergo non contrast CT scan and will be evaluated only for the primary objective
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of bony metastasis in Whole Body LDCT as compared to skeletal scintigraphy Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection of pulmonary, visceral and nodal metastasis in LDCT compared to CD CT Timepoint: Baseline | — |
Countries
India
Contacts
Public ContactLipton mitra
All India Institute Of Medical Science
Outcome results
None listed